Evaluated by: David B. Kaminsky, M.D., FIAC, January 13, 2018
Original release date: February 5, 2018
Access to this course expires on: January 13, 2021, at 11:59 PM (PT)
CME 13 /SAMs 12.5
This course has been revised to emphasize the procedural aspects of ultrasound-guided fine needle aspiration biopsies and to compare the appearance of samples in cellular and core histologic formats to optimize ancillary studies and rapid diagnoses.
Challenge areas in diagnostic cytopathology are given particular attention - pancreas, liver, lung and kidney pathology is evolving in criteria, classification and nomenclature, and renal lesions have particular genomic and immunohistochemical profiles. Bone and soft tissue will be seen with a refreshing eye that engages the inquisitive and daring.
Whether you're a committed cytopathologist or a pathologist confronted with cytopathology in your general practice, this course will update your knowledge and stimulate your comprehension and confidence.
Practicing academic and community pathologists, and pathologists-in-training
Upon completion of this educational activity, learners will be able to:
Continuing Medical Education and Continuing Certification
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 13 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) and Lifelong Learning (Part II) credit for the purpose of meeting the ABPath requirements for Continuing Certification (CC). Registrants must take and pass the post-test in order to claim SAMs credit. Physicians can earn a maximum of 12.5 SAM/Part II credit hours.
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The following faculty reported no relevant financial relationships: Ivan A. Chebib, M.D., FRCPC, William Faquin, M.D., Ph.D., Yael K. Heher, M.D., MPH, FRCPC, David B. Kaminsky, M.D., FIAC, Sara E. Monaco, M.D., Sinchita Roy-Chowdhuri, M.D., Edward Stelow, M.D.
USCAP staff associated with the development of content for this activity reported no relevant financial relationships.
To earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing score of 80%, they have the option to retake the exam. After you pass the test and complete the evaluation, your certificate of completion will be available to view and print by clicking here.
Buy the entire 2018 Diagnostic Cytopathology course and get a great discount!
Not A Member? Click Here
This item is expired.
Items Included in the Purchase of this Course
Current Role of FNA Biopsy and HPV Testing in Head and Neck Cancers
Molecular Diagnostics in FNA and Core Biopsies - Part 1
Molecular Diagnostics in FNA and Core Biopsies - Part 2
Managing Error and Disclosure Related to FNA and Core Biopsies
Contemporary Approach to FNA and Core Biopsies of Soft Tissue Lesions
Contemporary Approach to FNA and Core Biopsies of Bone Lesions
EBUS FNA and Mini Biopsies: Challenges in the Mediastinum and Lung
Problematic Areas and Solutions in Pancreatic FNA and Core/Small Biopsies
Unusual Salivary Gland Lesions Characterized by Needle Biopsies
Thyroid Re-Imagined with FNA and Mini Biopsies (cell blocks)
FNA Biopsy and CORE Principles in Liver Cytology